Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    PARP-Inhibitor Combination Treatments: Biomarker Testing, Safety, and Efficacy in a Rapidly Changing Metastatic Prostate Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Review and analysis of serotype distribution and burden of pneumococcal disease in children younger than 5 years – Post vac era
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines Burkina Faso, Congo, The Democratic Republic, Cote D'ivoire, Ethiopia, Ghana, Mozambique, Pakistan, Senegal, Sudan, Tanzania, United Republic of
    The Clinical Application of ATM-AVI in Patients with CRE Infections, including MBL-Producing CRE
    Release Date:
    Review Process: Pfizer Internal
    Research Hospital China, Hong Kong
    COVID-19 Disease Burden on the High Risk Population
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines All
    New Research Areas to Improve Diagnosis and Treatment of Inflammatory Bowel Disease
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology USA
    Actionable Biomarker and Genetic Testing in Cancer: Education for Advanced Practice Providers (APPs)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Unmet Needs and Emerging Data in Patients with High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC)
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology USA
    Interdisciplinary Collaboration for the Management of Severe Alopecia Areata in Patients with Comorbidities
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Antimicrobial Stewardship in the Sub-Saharan African Region
    Release Date:
    Partner: International Society for Infectious Diseases
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology All
    Enhancing Patient-Centered Outcomes in Emergency Department Migraine Management
    Release Date:
    Partner: American College of Emergency Physicians (ACEP)
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine USA
    Maintenance Therapy in HER2+ Metastatic Breast Cancer (MBC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Updates in RSV Prevention for Prenatal Care Workers Serving Marginalized Communities
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Acquired Aplastic Anemia: Educational programs to upskill hematologists & primary care physicians with current best practices
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Bridging the Inflammatory Dermatosis Care Divide with Teledermatology
    Release Date:
    Partner: The George Washington University
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology USA
    Knowledge Gaps in Drug-Drug Interactions in COVID-19 Outpatient Treatment
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Optimizing COVID-19 Treatment Strategies in Elderly Vulnerable Populations in Canada
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Quality Improvement Vaccines Canada
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Canada
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Research Rare Disease Canada
    Improving access to and the quality of clinical diagnostic solutions (Africa Geographic Scope)
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Support for the Professions All
    Patient Education and Support for the Management of Migraine
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine All
    Advancing Management and Care in Atrial Fibrillation and Venous Thromboembolism (ex-US)
    Release Date:
    Partner: Bristol-Myers Squibb
    Review Process: Pfizer Internal
    Education Internal Medicine All
    Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
    Release Date:
    Partner: Global Bridges at Mayo Clinic
    Review Process: Expert Review Panel
    Quality Improvement Rare Disease All
    Accord for a Healthier World: Antimicrobial Resistance Testing & Stewardship to Improve Hospitalized Patients’ Health Outcomes
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Hospital Malawi, Rwanda, Senegal
    Updates in Post-COVID Conditions: Potential Causes, Assessment, Testing, Management, and Ongoing Research
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA